| Name | Title | Contact Details |
|---|
Headquartered in Alexandria, VA, UIC Technical Services (UICTS) is an Alaska Native 8(a) Holding Company committed to delivering the best quality, the best value and the best product tailored to our client's needs. UICTS and its Bowhead family of companies provide defense, government and private sector customers with expertise in areas such as program management, systems engineering/ integration, weapon systems acquisition management, logistics/supply support, software development, IT services support, risk management, training/simulation support, products procurement, and administrative services support. UICTS and its Bowhead companies are subsidiaries of the Ukpeagvik Inupiat Corporation of Barrow, Alaska.
Mailgun is an email automation service designed for developers. It offers a suite of powerful APIs that allow developers to send, receive and track email with ease. From transactional emails to newsletters, Mailgun streamlines the delivery process and ...
Communication for the classroom, home, and everywhere in between. Remind is a communication platform that helps schools and districts reach and engage with their communities—and build the relationships that lead to better learning.
C5i Corporation is a profitable privately held company that has been funded by private investors. The company continues to invest in building its host of managed security services, expansion of worldwide Security Command Centers, applications
Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.